Manufacturer ordered to recall 'substandard, adulterated' injections from market.

ISLAMABAD -- Drug Regulatory Authority of Pakistan (DRAP) has directed a drug manufacturing company to immediately recall its defected batch of a product from the market. According to a recall alert issued by DRAP, all pharmacists and chemists working at distributions and pharmacies have been asked to immediately return the stock of a batch of product to the supplier, importer, and the company. The Central Drugs Laboratory Karachi had declared that batch No. CIJI70 of Paracet 1g/100ml Infusion, active ingredients of Paracetamol, manufactured by M/s. Standpharm...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT